IceCure Medical is setting new standards in minimally-invasive cryotherapy for women's health and interventional oncology. The ProSense Cryoablation System uses Liquid Nitrogen technology to destroy benign and cancerous tumors by freezing them at extremely low temperatures, without surgery.
+972-4-623-0333
Our Representatives
Company Solutions
ProSense™ Cryoablation System
The ProSense™ system is an effective liquid nitrogen (LN2) cryoablation solution, capable of destroying tumors safely, quickly and painlessly, without the need for surgery.
HOW IT WORKS
IceCure’s unique ultra-slim probe freezes targeted tissue within minutes using advanced cryotherapy technology.
Guided by CT or ultrasound, the probe is inserted into the tumor and liquid nitrogen generates sub-zero temperatures to turn the tumor into an ice ball. A freeze-thaw-freeze cycle destroys the targeted tissue immediately and leaves adjacent healthy tissue undamaged. The necrotic debris is eventually absorbed by the body. Each procedure is easily customized and controlled from the ProSense™ console.
PROSENSE™ SYSTEM ADVANTAGES
- In-office treatment options - no hospital admission and waiting
- Safe & Effective - clinically provide to destroy tumors, FDA cleared, CE marked
- Fast procedure - Can be less than 30 minutes
- Low risk of infections and complications
- Cosmetically superior - no deformation or scarring
- Minimally invasive - only a thin probe is inserted directly into the treatment area
- No pain, mild sedation - local cooling prevents pain
- Immediate recovery - get back to your daily routines quickly
FOR BREAST TUMOR THERAPY
ProSense™ is the optimal solution for breast tumors, enabling quicker in‐office treatment. Choosing our liquid nitrogen-based technology, patients accomplish painless therapy and physicians achieve better outcomes. Provide patients with safe and fast cryoablation therapy for breast tumors. Liquid nitrogen-based ProSense™ treatment rapidly and effectively destroys fibroadenomas and malignant tumors with an advanced probe and console setup.
FOR INTERVENTIONAL RADIOLOGY
Our cryoablation therapy extends into interventional oncology. Current studies show favorable results treating kidney, lung, liver, and bone cancer tumors.
Looking For
IceCure Medical is looking for new distribution channels and investors.
The company recently closed a $15 million private investment and intends to pursue a NASDAQ listing in 2021.